Platinum Chemotherapy Hypersensitivity Prevalence and Management

被引：46
|
作者：
Otani, Iris M. [1 ]
Wong, Johnson [2 ]
Banerji, Aleena [2 ]
机构：
[1] UCSF Med Ctr, Div Pulm Crit Care Allergy & Sleep Med, Dept Med, 400 Parnassus Ave,Fifth Floor, San Francisco, CA 94143 USA
[2] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Dept Med, 55 Fruit St, Boston, MA 02114 USA
来源：
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2017年 / 37卷 / 04期
关键词：
Platinum agent; Carboplatin; Cisplatin; Oxaliplatin; Chemotherapy allergy; Chemotherapy hypersensitivity; Chemotherapy desensitization; CARBOPLATIN HYPERSENSITIVITY; SKIN-TEST; RISK-STRATIFICATION; OVARIAN-CANCER; DESENSITIZATION PROTOCOL; RAPID DESENSITIZATION; CROSS-REACTIVITY; COMPLEX SALTS; OXALIPLATIN; CISPLATIN;
D O I：
10.1016/j.iac.2017.06.003
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Hypersensitivity reactions to platinum agents are common. For carboplatin and cisplatin, the first hypersensitivity reaction typically occurs around the second and third re-exposure during the second line of therapy (eighth and ninth courses overall). For oxaliplatin, the first hypersensitivity reaction can occur throughout the treatment course. Skin testing helps risk stratify patients to appropriate desensitization protocols and assess risk for breakthrough HSRs during desensitization. A risk-stratification protocol using 3 serial skin tests and desensitization protocols enables patients with platinum agent hypersensitivity to receive first-line chemotherapy treatment safely.
引用
收藏
页码：663 / +
页数：17
相关论文
共 50 条
  • [41] Advances in platinum chemotherapy
    Stoddart, A
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2006, 4 (03) : B6 - B6
  • [42] Advances in platinum chemotherapy
    Stoddart, A
    MOLECULAR BIOSYSTEMS, 2006, 2 (02) : B6 - B6
  • [43] Advances in platinum chemotherapy
    Stoddart, A
    NATURAL PRODUCT REPORTS, 2006, 23 (01) : B6 - B6
  • [44] Outpatient desensitization is an effective and safe management option for platinum hypersensitivity reactions: A single institution experience
    Vetter, M. H.
    Khan, A.
    Backes, F. J.
    Bixel, K.
    Cohn, D. E.
    Copeland, L. J.
    Fowler, J. M.
    Salani, R.
    O'Malley, D. M.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 251 - 252
  • [45] DEVELOPMENT AND IMPLEMENTATION OF CHEMOTHERAPY ADMINISTRATION, MANAGEMENT OF HYPERSENSITIVITY REACTION, EXTRAVASATION AND SPILL COMPETENCY FOR NURSES
    Kennihan, Heather
    ONCOLOGY NURSING FORUM, 2015, 42 (02) : E173 - E174
  • [46] Incidence And Prevalence Of Hypersensitivity Pneumonitis
    Perez, E. Fernandez
    Farr, A.
    Raimundo, K.
    Kulkarni, R.
    Cole, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [47] Survival and prevalence of platinum resistance following interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy
    Jou, Jessica
    Zimmer, Zoe
    Plaxe, Steven Charles
    McHale, Michael T.
    Saenz, Cheryl C.
    Eskander, Ramez N.
    Binder, Pratibha Sareen
    GYNECOLOGIC ONCOLOGY, 2020, 159 (02) : E13 - E13
  • [48] Prevalence of neoplasia at colonoscopy among testicular cancer survivors treated with platinum-based chemotherapy
    Breekveldt, Emilie C. H.
    Ykema, Berbel L. M.
    Bisseling, Tanya M.
    Moons, Leon M. G.
    Spaander, Manon C. W.
    Huibregtse, Inge L.
    van Der Biessen-van Beek, Dorien T. J.
    Mulder, Sasja F.
    Saveur, Lisette
    Kerst, J. Martijn
    Zweers, Danielle
    Suelmann, Britt B. M.
    de Wit, Ronald
    Reijm, Agnes
    van Baalen, Sophia
    Butterly, Lynn F.
    Hisey, William M.
    Robinson, Christina M.
    van Vuuren, Anneke J.
    Carvalho, Beatriz
    Lansdorp-Vogelaar, Iris
    Schaapveld, Michael
    van Leeuwen, Flora E.
    Snaebjornsson, Petur
    van Leerdam, Monique E.
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (08) : 1474 - 1483
  • [49] Severe hypersensitivity reactions to platinum compounds post-pressurized intraperitoneal aerosol chemotherapy (PIPAC): first literature report
    Matthieu Siebert
    Mohammad Alyami
    Frederic Mercier
    Colin Gallice
    Laurent Villeneuve
    Frédéric Bérard
    Olivier Glehen
    Naoual Bakrin
    Vahan Kepenekian
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 425 - 430
  • [50] Severe hypersensitivity reactions to platinum compounds post-pressurized intraperitoneal aerosol chemotherapy (PIPAC): first literature report
    Siebert, Matthieu
    Alyami, Mohammad
    Mercier, Frederic
    Gallice, Colin
    Villeneuve, Laurent
    Berard, Frederic
    Glehen, Olivier
    Bakrin, Naoual
    Kepenekian, Vahan
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (03) : 425 - 430
12345